Self-reported side-effects of anti-retroviral treatment among IDUs: A 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)

International Journal of Drug Policy

Volumn 18, Issue 4, 2007, Pages 288-295

  Carrieri, Maria Patrizia ^a,b   Villes, Virginie ^a,b   Raffi, François ^c   Protopopescu, Camelia ^a,b   Preau, Marie ^a,d   Salmon, Dominique ^e   Taieb, Audrey ^a   Lang, Jean Marie ^f   Verdon, Renaud ^g   Chene, Geneviève ^a   Spire, Bruno ^a,b  

^a INSERM   (France)

^b OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^c HÔTEL DIEU   (France)

^d UNIVERSITÉ DE NANTES   (France)

^e Service de Médecine Interne II Hôpital Cochin Port Royal ^*  (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g CHU CÔTE DE NACRE   (France)

Author keywords

Anti retroviral treatment; HIV; Hyperalgesia; Injecting drug users; Pain; Side effects

Indexed keywords

ANALGESIC AGENT; ANTIRETROVIRUS AGENT; BUPRENORPHINE; COCAINE; INDINAVIR; METHADONE; MORPHINE; NELFINAVIR; RITONAVIR; SAQUINAVIR;

ABDOMINAL PAIN; ADULT; ARTICLE; BONE DISEASE; CLINICAL PRACTICE; COHORT ANALYSIS; CORRELATION ANALYSIS; DEPRESSION; DIARRHEA; DRUG DEPENDENCE; DRUG EXPOSURE; DRUG USE; DRY SKIN; FATIGUE; FEMALE; FEVER; FOLLOW UP; HAIR LOSS; HALLUCINATION; HEADACHE; HEARTBURN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERALGESIA; INJECTING DRUG USER; INSOMNIA; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; NAIL DISEASE; NAUSEA; NEPHROLITHIASIS; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN PRURITUS; SOCIAL STATUS; SUBSTITUTION THERAPY; TASTE; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34547183477     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.01.014     Document Type: Article

References (38)

1. Ammassari A., Antinori A., Aloisi M.S., Trotta M.P., Murri R., Bartoli L., et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 45 5 (2004) 394-402
2. Ammassari A., Murri R., Pezzotti P., Trotta M.P., Ravasio L., De Longis P., et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes 28 5 (2001) 445-449
3. Bassetti S., Battegay M., Furrer H., Rickenbach M., Flepp M., Kaiser L., et al. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes 21 2 (1999) 114-119
4. Bissell D., Paton A., and Ritson B. ABC of alcohol help: Referral. British Medical Journal (Clinical Research Edition) 284 6314 (1982) 495-497
5. Bouhnik A.D., Chesney M., Carrieri P., Gallais H., Moreau J., Moatti J.P., et al. Nonadherence among HIV-infected injecting drug users: The impact of social instability. Journal of Acquired Immune Deficiency Syndromes 31 Suppl. 3 (2002) S149-S153
6. Bouhnik A.D., Preau M., Vincent E., Carrieri M.P., Gallais H., Lepeu G., et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antiviral Therapy 10 1 (2005) 53-61
7. Breitbart W., Passik S., McDonald M.V., Rosenfeld B., Smith M., Kaim M., et al. Patient-related barriers to pain management in ambulatory AIDS patients. Pain 76 1-2 (1998) 9-16
8. Breitbart W., Rosenfeld B., Passik S., Kaim M., Funesti-Esch J., and Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain 72 1-2 (1997) 235-243
9. Carrieri M.P., Chesney M.A., Spire B., Loundou A., Sobel A., Lepeu G., et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioral Medicine 10 1 (2003) 1-14
10. Carrieri M.P., Moatti J.P., Vlahov D., Obadia Y., Reynaud-Maurupt C., and Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use MANIF 2000 Study Group. Journal of Epidemiology Community Health 53 1 (1999) 4-8
11. Carrieri M.P., Raffi F., Lewden C., Sobel A., Michelet C., Cailleton V., et al. Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year follow-up study. Antiviral Therapy 8 6 (2003) 585-594
12. Celentano D.D., Galai N., Sethi A.K., Shah N.G., Strathdee S.A., Vlahov D., et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. Aids 15 13 (2001) 1707-1715
13. Celerier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process. Journal of Neuroscience 21 11 (2001) 4074-4080
14. Compton P., Charuvastra V.C., and Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Dependence 63 2 (2001) 139-146
15. Cruess D.G., Douglas S.D., Petitto J.M., Leserman J., Ten Have T., Gettes D., et al. Association of depression, CD8+ T lymphocytes, and natural killer cell activity: Implications for morbidity and mortality in Human immunodeficiency virus disease. Current Psychiatry Report 5 6 (2003) 445-450
16. Darke S., Heather N., Hall W., Ward J., and Wodak A. Estimating drug consumption in opioid users: Reliability and validity of a 'recent use' episodes method. British Journal of Addiction 86 10 (1991) 1311-1316
17. Duran S., Spire B., Raffi F., Walter V., Bouhour D., Journot V., et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials 2 1 (2001) 38-45
18. Ferrando S.J., Rabkin J.G., de Moore G.M., and Rabkin R. Antidepressant treatment of depression in HIV-seropositive women. Journal of Clinical Psychiatry 60 11 (1999) 741-746
19. Fuhrer R., and Rouillon F. La version française de l'échelle CES-D Description and translation of the autoevaluation scale. Psychiatrie et Psychobiologie 4 (1989) 163-166
20. Justice A.C., Holmes W., Gifford A.L., Rabeneck L., Zackin R., Sinclair G., et al. Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology 54 Suppl. 1 (2001) S77-S90
21. Kerr T., Palepu A., Barness G., Walsh J., Hogg R., Montaner J., et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antiviral Therapy 9 3 (2004) 407-414
22. Key Facts on HIV Treatment for Injecting Drug Users Coalition ARV4IDUs [Electronic Version]. International Harm Reduction development program from http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/factarv_20040712.
23. Langendam M.W., van Haastrecht H.J., and van Ameijden E.J. The validity of drug users' self-reports in a non-treatment setting: Prevalence and predictors of incorrect reporting methadone treatment modalities. International Journal of Epidemiology 28 3 (1999) 514-520
24. Larue F., Fontaine A., and Colleau S.M. Underestimation and undertreatment of pain in HIV disease: Multicentre study. BMJ 314 7073 (1997) 23-28
25. McCormack J.P., Li R., Zarowny D., and Singer J. Inadequate treatment of pain in ambulatory HIV patients. Clinical Journal of Pain 9 4 (1993) 279-283
26. Nunez M., Gonzalez de Requena D., Gallego L., Jimenez-Nacher I., Gonzalez-Lahoz J., and Soriano V. Higher efavirenz plasma levels correlate with development of insomnia. Journal of Acquired Immune Deficiency Syndromes 28 4 (2001) 399-400
27. Passik S.D., Kirsh K.L., Donaghy K.B., and Portenoy R.K. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clinical Journal of Pain 22 2 (2006) 173-181
28. Perkins D.O., Leserman J., Stern R.A., Baum S.F., Liao D., Golden R.N., et al. Somatic symptoms and HIV infection: Relationship to depressive symptoms and indicators of HIV disease. American Journal of Psychiatry 152 12 (1995) 1776-1781
29. Reid S., and Dwyer J. Insomnia in HIV infection: A systematic review of prevalence, correlates, and management. Psychosomatic Medicine 67 2 (2005) 260-269
30. Rubinstein M.L., and Selwyn P.A. High prevalence of insomnia in an outpatient population with HIV infection. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 19 3 (1998) 260-265
31. Spire B., Duran S., Souville M., Leport C., Raffi F., and Moatti J.P. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Social Science Medicine 54 10 (2002) 1481-1496
32. Turner B.J., Laine C., Cosler L., and Hauck W.W. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. Journal of General Internal Medicine 18 4 (2003) 248-257
33. Vincent E., Bouhnik A.D., Carrieri M.P., Rey D., Dujardin P., Granier F., et al. Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up. Aids 18 9 (2004) 1321-1325
34. Vogl D., Rosenfeld B., Breitbart W., Thaler H., Passik S., McDonald M., et al. Symptom prevalence, characteristics, and distress in AIDS outpatients. Journal of Pain and Symptom Management 18 4 (1999) 253-262
35. White J.M. Pleasure into pain: The consequences of long-term opioid use. Addictive Behaviors 29 7 (2004) 1311-1324
36. Wood E., Hogg R.S., Yip B., Harrigan P.R., O'Shaughnessy M.V., and Montaner J.S. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0 200 to 0. 350 × 10(9) cells/L. Annals of Internal Medicine 139 10 (2003) 810-816
37. Wood E., Montaner J.S., Yip B., Tyndall M.W., Schechter M.T., O'Shaughnessy M.V., et al. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 169 7 (2003) 656-661
38. Yun L.W., Maravi M., Kobayashi J.S., Barton P.L., and Davidson A.J. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome 38 4 (2005) 432-438